CEACAM5 and lung carcinoma: Compared with those patients with early-stage disease, serum levels of CEA and IL-8 in patients with late-stage lung cancer were significantly increased, but the levels of IL-1β and IL-6 had no change significantly, which is inconsistent with the results of Xie et al.